PMID: 2490834May 1, 1989Paper

Socioeconomic status in the epidemiology and treatment of hypertension

Hypertension
H A Tyroler

Abstract

The association of socioeconomic status (SES), as indexed by educational achievement, with the prevalence, prognosis, and efficacy of treatment of hypertension in the Hypertension Detection and Follow-up Program (HDFP) was reviewed. The prevalence of hypertension varied inversely with SES during the screening program initiated to identify HDFP eligibles in 14 communities in 1973-1974. There was a strong inverse gradient of 5-year all-cause mortality with SES among the hypertensive participants referred to usual care in the HDFP. The association of mortality with SES among hypertensive subjects was eliminated by the HDFP stepped-care program. A large portion of the efficacy of the HDFP was associated with in-trial blood pressure control. Inasmuch as these results are generalizable to the nation, a large fraction of hypertension-associated morbidity and mortality in the United States was related to lower SES in the 1970s, before widespread implementation of programs resulting in increased awareness, treatment, and control of hypertension.

References

Jan 1, 1987·Annual Review of Public Health·M G MarmotM A Elston
May 1, 1983·American Journal of Epidemiology·R J Hardy, C M Hawkins

❮ Previous
Next ❯

Citations

Jul 8, 2011·International Journal of Public Health·Ulrich LaaserVesna Bjegovic
Oct 27, 2004·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Renee F RobinsonJohn D Mahan
Sep 9, 2008·Current Hypertension Reports·Deborah MinorSharon B Wyatt
Jul 25, 2009·Current Treatment Options in Cardiovascular Medicine·Randy WexlerDavid Feldman
Sep 30, 1996·The American Journal of Medicine·K Jamerson, V DeQuattro
Sep 12, 2000·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·D P MisraC Weisman
Aug 2, 2003·American Journal of Public Health·Lewis H Kuller
Jun 1, 2001·Paediatric and Perinatal Epidemiology·D P MisraD Strobino
Mar 1, 1994·Kidney International·E W YoungR A Wolfe
Jul 4, 2007·Public Health·A J ThomasUNKNOWN Multiple Risk Factor Intervention Trial (MRFIT) Research Group
Dec 25, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Ricardo SessoMarcos B Ferraz
Feb 1, 1996·American Heart Journal·R F Gillum
Oct 1, 1996·Journal of the American Geriatrics Society·M A EspelandJ Bahnson
Oct 19, 2001·Journal of Human Hypertension·M A TedescoA Iacono
Feb 15, 1992·BMJ : British Medical Journal·K BeardS Webb
Jul 6, 2017·Cadernos de saúde pública·Larissa Aline Carneiro LoboMarcos Pascoal Pattussi
Jul 1, 1993·Journal of the American Geriatrics Society·J M StarrP A Shering

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.